Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine pharmacokinetics and pharmacogenetics in migraine
ChiCTR2300068058Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tizanidine in migraine (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Tizanidine concentration. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
tizanidine
03
Conditions
migraine
Beyond the preview
Go deeper on ChiCTR2300068058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068058.